| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |